<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Peak expiratory flow monitoring in asthma</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Peak expiratory flow monitoring in asthma</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Peak expiratory flow monitoring in asthma</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lynn B Gerald, PhD, MSPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tara F Carr, MD, FAAAAI</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Meredith C McCormack, MD, MHS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert A Wood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 14, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The peak expiratory flow (PEF, also known as a peak flow or peak flow rate) is the maximal rate that a person can exhale during a short maximal expiratory effort after a full inspiration. In patients with asthma, the PEF percent predicted correlates reasonably well with the percent predicted value for the forced expiratory volume in one second (FEV<sub>1</sub>) and provides an objective measure of airflow limitation when spirometry is not available [<a href="#rid1">1,2</a>]. </p><p>PEF monitoring in patients with asthma will be reviewed here. Other aspects of asthma diagnosis and management are presented separately. (See  <a class="medical medical_review" href="/d/html/5742.html" rel="external">"Asthma in children younger than 12 years: Initial evaluation and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/543.html" rel="external">"Asthma in adolescents and adults: Evaluation and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/547.html" rel="external">"An overview of asthma management"</a> and  <a class="medical medical_review" href="/d/html/5735.html" rel="external">"Overview of pulmonary function testing in children"</a> and  <a class="medical medical_review" href="/d/html/569.html" rel="external">"Pulmonary function testing in asthma"</a> and  <a class="medical medical_patient" href="/d/html/371.html" rel="external">"Patient education: Asthma treatment in adolescents and adults (Beyond the Basics)"</a>.)</p><p class="headingAnchor" id="H326484413"><span class="h1">BACKGROUND</span></p><p class="headingAnchor" id="H3958201222"><span class="h2">Physiology</span><span class="headingEndMark"> — </span>During a maximal expiratory effort from total lung capacity, the peak expiratory flow occurs in the first 200 milliseconds, which is in the effort dependent portion of expiration. PEF is affected by the fullness of the preceding inspiration, caliber of the large airways, expiratory muscle strength, and voluntary effort. As might be expected, PEF can vary substantially with patient effort and coordination.</p><p>PEF measurement predominantly assesses large airway caliber and can underestimate the effects of asthma in the small airways. (See <a class="local">'Limitations'</a> below.)</p><p class="headingAnchor" id="H2001309846"><span class="h2">Peak flow meters</span><span class="headingEndMark"> — </span>PEF is typically measured with a peak flow meter, although it can also be measured during routine spirometry. Most peak flow meters are small mechanical devices, although electronic peak flow devices are also available.</p><p>Devices from different manufacturers tend to vary in reproducibility and accuracy, and there is no simple method for calibrating individual devices [<a href="#rid3">3</a>]. International standards for accuracy and reliability have been published, and devices that meet these standards should be selected [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H2375414117"><span class="h2">Technique</span><span class="headingEndMark"> — </span>The technique for performing PEF measurements should include the following steps, as described in the table (<a class="graphic graphic_table graphicRef53856" href="/d/graphic/53856.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Move peak flow meter indicator to zero.</p><p class="bulletIndent1"><span class="glyph">●</span>Sit or stand up straight.</p><p class="bulletIndent1"><span class="glyph">●</span>Take in a deep breath, as deep as you can.</p><p class="bulletIndent1"><span class="glyph">●</span>Place peak flow meter in your mouth and close your lips tightly around the mouthpiece. Do not put your tongue against or inside the hole.</p><p class="bulletIndent1"><span class="glyph">●</span>Blow out as hard and fast as you can using your chest and belly muscles; this should take no more than two seconds.</p><p class="bulletIndent1"><span class="glyph">●</span>Write down the result.</p><p class="bulletIndent1"><span class="glyph">●</span>Repeat two more times (three total).</p><p class="bulletIndent1"><span class="glyph">●</span>Record the highest of the three values.</p><p></p><p>When patients are first instructed in home monitoring of PEF, they should be asked to demonstrate the use of the peak flow meter for the provider, who can then assess proper technique and make necessary adjustments. An online video demonstrating <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DxjNRnba0L-0&amp;token=3BBziCZQDrEhIlt93szQloH6eZnp6PMXkxC7JnVMP%2FW0UB2qKlaAAg3KV9mFaueaivw21RRx1EA5h1QSylnrUQ%3D%3D&amp;TOPIC_ID=568" target="_blank">PEF technique</a> may be helpful [<a href="#rid5">5</a>].</p><p>The patient's technique should be reviewed at follow-up visits to ensure that it remains correct. Without ongoing review of PEF technique and diaries, recorded PEF values tend to decline, possibly caused by reduced expiratory effort [<a href="#rid6">6</a>]. (See  <a class="medical medical_patient" href="/d/html/366.html" rel="external">"Patient education: How to use a peak flow meter (Beyond the Basics)"</a>.)</p><p>When patients are taught how to record and interpret their PEF, it is helpful to explain that it is important to monitor variability in addition to the absolute value [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H406739940"><span class="h2">Normal values</span><span class="headingEndMark"> — </span>Normal values for PEF depend on sex, age, and height, similar to spirometric values for forced expiratory volume in one second (FEV<sub>1</sub>) and forced vital capacity (FVC). When measured using a peak flow meter, PEF values are usually expressed as L/min; when measured as part of spirometry, values are expressed in L/sec. To convert, multiply L/sec x 60 sec/min = L/min.</p><p>PEF values can be compared to age, sex, and height-matched normal subjects (<a class="graphic graphic_table graphicRef57257 graphicRef62839 graphicRef64420" href="/d/graphic/57257.html" rel="external">table 2A-C</a>) and (<a class="calc calc_professional" href="/d/html/126051.html" rel="external">calculator 1</a> and <a class="calc calc_professional" href="/d/html/126050.html" rel="external">calculator 2</a>). UpToDate calculators for PEF predicted values include adjustments for race/ethnicity in addition to age, sex, and height (<a class="calc calc_professional" href="/d/html/126051.html" rel="external">calculator 1</a> and <a class="calc calc_professional" href="/d/html/126050.html" rel="external">calculator 2</a>) [<a href="#rid7">7</a>]. When determining predicted PEF values, the reference values should be derived from a peak flow meter, rather than spirometric values, as the latter tend to be lower than peak flow meter predicted values [<a href="#rid8">8</a>]. The lower values may be due to the prolonged expiratory effort of spirometry compared with the brief and rapid exhalation used with a peak flow meter. However, for purposes of asthma monitoring, instead of using predicted PEF, patients should establish a personal best. (See <a class="local">'Determining personal best PEF'</a> below.)</p><p>Diurnal variation with slightly lower PEF values in the morning than in the afternoon-evening are common [<a href="#rid9">9</a>]. The daily peak is usually between 1400 and 1600 hours. In a study of healthy schoolchildren, the mean variability in PEF was 6.2 percent [<a href="#rid10">10</a>]. The amount of diurnal variation is usually less than 20 percent when asthma is well-controlled. Ongoing assessment of diurnal variation is hampered by the cumbersome calculation of diurnal variation and the potential introduction of error by small changes in the exact time of measurement [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H2717848108"><span class="h2">Correlation with asthma symptoms and spirometry</span><span class="headingEndMark"> — </span>PEF generally correlates with symptoms as assessed by the Asthma Control Test (ACT) [<a href="#rid12">12-14</a>], although the correlation is less good in overweight patients [<a href="#rid13">13</a>].</p><p>A recent systematic literature review suggested that PEF could be particularly helpful as a monitoring tool for patients who are identified as having poor perception of symptoms [<a href="#rid15">15</a>].</p><p>Spirometry measures a key indicator of airflow limitation, the FEV<sub>1</sub>, which is the volume of air forcibly exhaled in the first second after a maximal inspiration. The correlation between percent predicted FEV<sub>1</sub> and PEF measured by peak flow meter is generally good [<a href="#rid16">16,17</a>], although broad differences can be seen [<a href="#rid18">18,19</a>].</p><p>For individual patients, PEF results should be correlated with spirometry to ensure that changes in PEF are sufficiently sensitive and specific for changes in airflow limitation. In one study of 197 patients with asthma, changes of 15 percent or more in FEV<sub>1</sub> between two clinic visits were not detected by PEF in up to 43 percent of participants; on the other hand, 33 percent of participants with less than a 15 percent change in FEV<sub>1</sub> had changes in PEF of 15 percent or more [<a href="#rid20">20</a>].</p><p class="headingAnchor" id="H3257619023"><span class="h2">Limitations</span><span class="headingEndMark"> — </span>The validity of PEF is dependent on maximal effort, and suboptimal technique can lead to low values in the absence of disease. The lack of graphic display on peak flow meters makes it difficult to ensure optimal technique and maximal patient effort. To improve reliability of PEF measurements, observing a patient during a PEF maneuver can help identify suboptimal effort or technique and guide further training.</p><p>Restrictive processes that limit full inspiration, such as chest wall disease, obesity, and muscle weakness, can lead to a reduced PEF in the absence of airflow limitation. Thus, values for PEF that are less than 80 percent of predicted should be further evaluated with spirometry before assuming that the abnormality is due to asthma.</p><p>While PEF generally has good sensitivity for COPD, it can underestimate the severity of airflow limitation and has low specificity; spirometry is preferred for diagnosis [<a href="#rid21">21,22</a>]. (See  <a class="medical medical_review" href="/d/html/1455.html" rel="external">"Chronic obstructive pulmonary disease: Diagnosis and staging", section on 'How to evaluate'</a>.)</p><p>In severe asthma, PEF can sometimes underestimate the degree of airflow limitation [<a href="#rid16">16,17</a>]. In a study of 244 children (age 4 to 18 years) with moderate to severe asthma, 30 percent of children with a normal PEF had an abnormal FEV<sub>1</sub> or forced expiratory flow (FEF; 25 to 75 percent) [<a href="#rid17">17</a>]. Increasing air trapping correlated with reduced accuracy of PEF relative to spirometry.</p><p class="headingAnchor" id="H169768839"><span class="h1">DETERMINING PERSONAL BEST PEF</span><span class="headingEndMark"> — </span>For patients who will be using PEF as part of an asthma self-management plan, one of the first steps is to determine the individual’s personal best peak flow. An individual’s personal best peak flow value can be higher or lower than the predicted value. Ideally, the baseline values should be obtained when the patient is feeling well after a period of maximal asthma therapy [<a href="#rid23">23</a>].</p><p>Given that individuals have day-to-day variability in PEF, an individual's normal range for PEF is defined as 80 and 100 percent of their personal best. Readings below this normal range, if not attributed to reduced effort, may indicate airway narrowing, which can occur prior to the onset of symptoms.</p><p>Each patient's personal best value must be reevaluated annually to account for growth in children and disease progression in both children and adults. PEF reaches a peak at about 18 to 20 years, maintains this level up to about 30 years in males, and about 40 years in females, and then declines with age [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H3551483878"><span class="h2">Peak flow diaries</span><span class="headingEndMark"> — </span>To determine their personal best PEF, patients should record PEF measurements in a peak flow diary two to four times daily for two weeks during a time when their asthma is well-controlled [<a href="#rid23">23</a>]. Peak flow diaries are usually provided with the device. Alternatively, sample diaries are provided in the graphics (<a class="graphic graphic_figure graphicRef62691" href="/d/graphic/62691.html" rel="external">figure 1</a> and <a class="graphic graphic_form graphicRef76505" href="/d/graphic/76505.html" rel="external">form 1</a> and <a class="graphic graphic_table graphicRef72953" href="/d/graphic/72953.html" rel="external">table 3</a>) and can also be downloaded from online resources, such as the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.nationalasthma.org.au%2Fhealth-professionals%2Fasthma-action-plans%2Fasthma-action-plan-library&amp;token=tDKdMWU1zteWD9GKbsSqI0YFS1VAQXGirv97agSBtLObkP9DCDGKYAyZK5D7eYWiK%2FLWdjj3VAcA%2FFSM5SI1XVcopTlWoRwfAd9LnksgdX8%3D&amp;TOPIC_ID=568" target="_blank">National Asthma Council Australia</a> and <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fshop.asthmaandlung.org.uk%2Fproducts%2Fpeak-flow-diary&amp;token=TDJzFPDMojXPCNlE7CGBGkJ7%2FISo4gVy9igX%2FDf01%2FSZ8YjPJ44rZjhZNl%2FIa7hMbyZL%2FfV3d6sdhqbOMqg1zw%3D%3D&amp;TOPIC_ID=568" target="_blank">Asthma UK</a>, or purchased [<a href="#rid25">25</a>]. </p><p>At the next visit, the peak flow diary is reviewed to determine patient's "personal best" PEF value. The personal best is generally the highest PEF measurement achieved during this post-treatment monitoring period, but can be revised subsequently if higher values are recorded. </p><p class="headingAnchor" id="H2631739290"><span class="h1">ASTHMA SELF-MANAGEMENT</span><span class="headingEndMark"> — </span>The optimal role of long- or short-term PEF monitoring in the ongoing management of asthma has not been determined. The theoretic advantage is that regular PEF monitoring can provide the patient and clinician with objective data upon which to base therapeutic decisions [<a href="#rid1">1,2</a>]. While randomized trials comparing symptom diaries with PEF monitoring have not shown that PEF monitoring improves asthma outcomes over symptom-based diaries [<a href="#rid12">12,26</a>], guidelines support the use of PEF monitoring to supplement other assessments of asthma control in patients with moderate-to-severe asthma [<a href="#rid1">1</a>]. We tailor the frequency of PEF monitoring to the needs of the individual patient [<a href="#rid27">27</a>]. </p><p>A patient who is a poor perceiver of asthma symptoms may benefit from assessment of PEF every morning and evening, rather than relying solely on symptoms to guide therapy. Another patient with more stable asthma may only need to measure PEF once or twice weekly, at a consistent time of day. Patients can increase PEF measurements when experiencing symptoms, or when they are at risk for an asthma flare such as during an upper respiratory infection or the pollen season.</p><p class="headingAnchor" id="H1286934154"><span class="h2">Asthma action plan</span><span class="headingEndMark"> — </span>An "asthma action plan" is a written document that provides instructions for the patient to follow at home. Many asthma specialists, including ourselves, believe that written asthma action plans are useful in clarifying the medication plan, identifying declines in asthma control, and guiding treatment adjustments in response to changes in symptoms and PEF [<a href="#rid1">1</a>]. Self-management education that includes monitoring of symptoms and/or PEF, a written action plan, and regular review of asthma care by a healthcare provider reduce asthma morbidity in both adults and children [<a href="#rid1">1,28</a>]. For patients who are incorporating PEF monitoring into their asthma action plan, we provide instruction on the rationale of PEF monitoring, use of a PEF diary, and interpretation of results in the context of a personalized asthma action plan (<a class="graphic graphic_form graphicRef55900" href="/d/graphic/55900.html" rel="external">form 2</a>). (See  <a class="medical medical_review" href="/d/html/566.html" rel="external">"Asthma education and self-management", section on 'Asthma action plans'</a>.)</p><p>The combination of monitoring subjective and objective measures of asthma control may help patients observe a cause-and-effect relationship between exposure to triggers and decrements in peak flow and/or exacerbations of asthma (<a class="graphic graphic_figure graphicRef62691" href="/d/graphic/62691.html" rel="external">figure 1</a>) [<a href="#rid25">25</a>]. The patient should understand that such monitoring is undertaken to check on the effectiveness of therapy and to give early warning of potential deterioration [<a href="#rid1">1,29</a>]. This approach may be particularly helpful for patients who have difficulty perceiving symptoms or exacerbating factors [<a href="#rid1">1,2</a>].</p><p class="headingAnchor" id="H3841102281"><span class="h2">GREEN YELLOW RED zones</span><span class="headingEndMark"> — </span>It is suggested that a zone scheme similar to a traffic light system be used to illustrate a plan upon which patients can base self-management decisions (<a class="graphic graphic_form graphicRef55900" href="/d/graphic/55900.html" rel="external">form 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>GREEN (80 to 100 percent of personal best) signals "all clear." When readings are within this range and symptoms are not present, the patient is advised to adhere to his or her regular maintenance regimen.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>YELLOW (50 to 80 percent of personal best) signals "caution," since the airways are somewhat obstructed. The patient should implement the treatment plan decided upon with the clinician to reverse airway narrowing and regain control [<a href="#rid30">30</a>]. The wide range represented by the yellow zone can be subdivided above and below the 65 percent level if desired.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>RED (below 50 percent of personal best) signals "warning or medical alert." Bronchodilator therapy should be started immediately, and the clinician should be contacted if PEF measures do not return immediately to the yellow or green zones.</p><p></p><p class="headingAnchor" id="H1896004020"><span class="h2">Adherence</span><span class="headingEndMark"> — </span>Adherence to long-term PEF monitoring is difficult to maintain [<a href="#rid31">31-33</a>]. According to some reports, adherence with home PEF recording is satisfactory in the short term, but falls off considerably after several months, which is a significant limitation to this form of monitoring [<a href="#rid34">34,35</a>]. While patient adherence to PEF monitoring is highly variable, connecting PEF monitoring to concrete self-management activities may increase adherence [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/d/html/556.html" rel="external">"Enhancing patient adherence to asthma therapy"</a>.)</p><p class="headingAnchor" id="H2839026207"><span class="h2">Efficacy</span><span class="headingEndMark"> — </span>Studies evaluating the efficacy of PEF monitoring for improving various outcome measures in asthma have yielded conflicting results [<a href="#rid26">26,37-49</a>]. A number of studies failed to demonstrate an advantage of using PEF monitoring over symptom monitoring to guide self-management actions [<a href="#rid26">26,37-39,42,44,45</a>]. Studies that demonstrated an improvement in outcomes, such as decreased health care utilization and improved quality of life, included a comprehensive management approach, which did not separate out the specific effect of PEF monitoring [<a href="#rid40">40,43,49</a>]. Further research is needed on ways to include objective measures of asthma control, such as peak flow monitoring, as a component of asthma self-management and on which patients are most likely to benefit. </p><p>PEF monitoring may be particularly important in asthma patients who have reduced perception of bronchoconstriction [<a href="#rid15">15</a>]. These patients usually have severe asthma and undertreat their asthma as symptoms are blunted so they need an objective measurement of airway obstruction.</p><p class="headingAnchor" id="H958152169"><span class="h1">USE OF PEF MONITORING IN OTHER SETTINGS</span><span class="headingEndMark"> — </span>Other settings in which monitoring of PEF may be useful include the acute care of asthma exacerbations in adults, home monitoring of asthma, and assessment of occupational asthma. PEF monitoring has a more limited role in the diagnosis of asthma and in the management of acute asthma exacerbations in children.</p><p>In the setting of the coronavirus disease 2019 (COVID-19) pandemic, asthma patient care has shifted to increased use of telephone and video visits and decreased use of office spirometry. Home PEF monitoring may be an increasingly useful tool for remote patient care in asthma. (See  <a class="medical medical_review" href="/d/html/126981.html" rel="external">"COVID-19: Epidemiology, virology, and prevention"</a>.)</p><p class="headingAnchor" id="H3116547418"><span class="h2">Assessing severity in acute asthma exacerbations</span><span class="headingEndMark"> — </span>Guidelines advise including PEF measurement as part of a combined assessment of severity and response to treatment in the acute care setting when managing asthma exacerbations in adults [<a href="#rid1">1,2,50</a>]. The use of PEF in this setting is described separately. (See  <a class="medical medical_review" href="/d/html/119093.html" rel="external">"Acute exacerbations of asthma in adults: Emergency department and inpatient management", section on 'Peak flow measurement'</a>.)</p><p>PEF is less commonly used in children with acute asthma exacerbations, especially if the child’s baseline PEF is not known. (See  <a class="medical medical_review" href="/d/html/91328.html" rel="external">"Acute asthma exacerbations in children younger than 12 years: Overview of home/office management and severity assessment", section on 'Peak flow rate'</a>.)</p><p class="headingAnchor" id="H936873601"><span class="h2">Diagnosis of asthma</span><span class="headingEndMark"> — </span>Spirometry assessment before and after bronchodilator is preferred over PEF monitoring in the diagnosis of asthma because spirometry provides more precise information, spirometers are easily calibrated, results are accompanied by predicted values for each patient, and examination of the flow-volume curves enables assessment of patient effort [<a href="#rid1">1,2</a>]. The spirometric diagnosis of asthma is discussed separately. (See  <a class="medical medical_review" href="/d/html/543.html" rel="external">"Asthma in adolescents and adults: Evaluation and diagnosis", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/d/html/5742.html" rel="external">"Asthma in children younger than 12 years: Initial evaluation and diagnosis", section on 'Diagnosis'</a>.) </p><p>When spirometry is not available, documentation of PEF variability may be used to support the diagnosis of asthma. Patients can be asked to record PEF upon awakening, in the afternoon-evening, with symptoms, and after use of inhaled bronchodilator. Peak flow variability is calculated as the difference between the maximum and minimum peak flow in a day, expressed as a percentage of that day's minimum PEF. Within-day or between-day variability in PEF (&gt;20 percent) that correlates with symptoms is characteristic of asthma [<a href="#rid51">51</a>]. (See  <a class="medical medical_review" href="/d/html/569.html" rel="external">"Pulmonary function testing in asthma", section on 'Peak expiratory flow'</a>.)</p><p class="headingAnchor" id="H3395304496"><span class="h2">Occupational asthma</span><span class="headingEndMark"> — </span>Serial measurement of PEF at work and away from work may be useful in the initial evaluation of occupational asthma. (See  <a class="medical medical_review" href="/d/html/550.html" rel="external">"Occupational asthma: Clinical features, evaluation, and diagnosis", section on 'Serial peak expiratory flow measurement'</a>.)</p><p class="headingAnchor" id="H746302973"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112325.html" rel="external">"Society guideline links: Asthma in adolescents and adults"</a>.)</p><p class="headingAnchor" id="H6"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/366.html" rel="external">"Patient education: How to use a peak flow meter (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H20410371"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>The peak expiratory flow (PEF, also known as peak flow or peak expiratory flow rate) is the maximal rate that a person can exhale during a short maximal expiratory effort after a full inspiration. (See <a class="local">'Background'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Monitoring the PEF is useful for detecting changes or trends in a patient's asthma control. However, significant testing variability makes it important to use a more reliable test, such as spirometry, to confirm or exclude airflow limitation suggested by the PEF. (See <a class="local">'Background'</a> above and  <a class="medical medical_review" href="/d/html/5735.html" rel="external">"Overview of pulmonary function testing in children"</a> and  <a class="medical medical_review" href="/d/html/569.html" rel="external">"Pulmonary function testing in asthma"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>PEF values can be compared with age, sex, and height-matched normal subjects to obtain a percent of predicted value for each patient (<a class="graphic graphic_table graphicRef57257 graphicRef62839 graphicRef64420" href="/d/graphic/57257.html" rel="external">table 2A-C</a>) (<a class="calc calc_professional" href="/d/html/126051.html" rel="external">calculator 1</a> and <a class="calc calc_professional" href="/d/html/126050.html" rel="external">calculator 2</a>). When determining predicted PEF values, the reference values should be derived from a peak flow meter, rather than spirometry. (See <a class="local">'Normal values'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When instructing a patient on use of a peak flow meter, the first step is to review the optimal technique (<a class="graphic graphic_table graphicRef53856" href="/d/graphic/53856.html" rel="external">table 1</a>). The patient should then be asked to demonstrate use of the peak flow meter, so the clinician can assess the technique and suggest adjustments, as needed. (See <a class="local">'Technique'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Typically, patients are asked to monitor and record their PEF two to four times daily (eg, morning, afternoon, with symptoms, after bronchodilator) for two weeks, ideally when their asthma is well controlled. Sample diaries are provided in the graphics (<a class="graphic graphic_figure graphicRef62691" href="/d/graphic/62691.html" rel="external">figure 1</a> and <a class="graphic graphic_form graphicRef76505" href="/d/graphic/76505.html" rel="external">form 1</a> and <a class="graphic graphic_table graphicRef72953" href="/d/graphic/72953.html" rel="external">table 3</a>) and can also be downloaded from online resources, such as the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.nationalasthma.org.au%2Fhealth-professionals%2Fasthma-action-plans%2Fasthma-action-plan-library&amp;token=tDKdMWU1zteWD9GKbsSqI0YFS1VAQXGirv97agSBtLObkP9DCDGKYAyZK5D7eYWiK%2FLWdjj3VAcA%2FFSM5SI1XVcopTlWoRwfAd9LnksgdX8%3D&amp;TOPIC_ID=568" target="_blank">National Asthma Council Australia</a> and <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fshop.asthmaandlung.org.uk%2Fproducts%2Fpeak-flow-diary&amp;token=TDJzFPDMojXPCNlE7CGBGkJ7%2FISo4gVy9igX%2FDf01%2FSZ8YjPJ44rZjhZNl%2FIa7hMbyZL%2FfV3d6sdhqbOMqg1zw%3D%3D&amp;TOPIC_ID=568" target="_blank">Asthma UK</a>. (See <a class="local">'Determining personal best PEF'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The two-week results are reviewed to determine the patient's "personal best" PEF value, which is generally the highest PEF measurement achieved during this post-treatment monitoring period. An individual patient's normal PEF range is defined as 80 and 100 percent of their personal best. This value is used to develop an "asthma action plan" (<a class="graphic graphic_form graphicRef55900" href="/d/graphic/55900.html" rel="external">form 2</a>). (See <a class="local">'Determining personal best PEF'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The frequency of long-term peak flow monitoring depends on the needs of the individual patient and the asthma action plan. Guidelines support the use of PEF monitoring to supplement other assessments of asthma control in patients with asthma. (See <a class="local">'Asthma self-management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other settings in which monitoring of PEF may be useful include the acute care of asthma exacerbations in adults and assessment of occupational asthma. PEF monitoring has a more limited role in the diagnosis of asthma and in the management of acute asthma exacerbations in children. (See <a class="local">'Use of PEF monitoring in other settings'</a> above.)</p><p></p><p class="headingAnchor" id="H2861314532"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges William Bailey, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">2023 Global Initiative for Asthma (GINA) Report: Global Strategy for Asthma Management and Prevention. www.ginasthma.org/2023-gina-main-report (Accessed on May 15, 2023).</li><li class="breakAll">National Asthma Education and Prevention Program: Expert Panel Report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD. National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051) www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on September 19, 2018).</li><li><a class="nounderline abstract_t">Tsukioka K. [Comparison of different types of peak flow meter and reference values for peak expiratory flow (PEF) for healthy Japanese subjects]. Nihon Rinsho 1996; 54:2927.</a></li><li class="breakAll">International Organization for Standardization. ISO 23747:2015: Anaesthetic and respiratory equipment -- Peak expiratory flow meters for the assessment of pulmonary function in spontaneously breathing humans. https://www.iso.org/obp/ui/#iso:std:64926:en (Accessed on September 20, 2018).</li><li class="breakAll">National Jewish Health. How to use a peak flow meter. https://www.youtube.com/watch?v=xjNRnba0L-0 (Accessed on October 08, 2018).</li><li><a class="nounderline abstract_t">Gannon PF, Belcher J, Pantin CF, Burge PS. The effect of patient technique and training on the accuracy of self-recorded peak expiratory flow. Eur Respir J 1999; 14:28.</a></li><li><a class="nounderline abstract_t">Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179.</a></li><li><a class="nounderline abstract_t">Pesola GR, O'Donnell P, Pesola GR, et al. Peak expiratory flow in normals: comparison of the mini Wright versus spirometric predicted peak flows. J Asthma 2009; 46:845.</a></li><li><a class="nounderline abstract_t">Bagg LR, Hughes DT. Diurnal variation in peak expiratory flow in asthmatics. Eur J Respir Dis 1980; 61:298.</a></li><li><a class="nounderline abstract_t">Brouwer AF, Roorda RJ, Duiverman EJ, Brand PL. Reference values for peak flow and FEV1 variation in healthy schoolchildren using home spirometry. Eur Respir J 2008; 32:1262.</a></li><li><a class="nounderline abstract_t">Reddel H, Jenkins C, Woolcock A. Diurnal variability--time to change asthma guidelines? BMJ 1999; 319:45.</a></li><li><a class="nounderline abstract_t">Kotses H, Harver A, Humphries CT. Home monitoring in asthma self-management. J Asthma 2006; 43:649.</a></li><li><a class="nounderline abstract_t">Buzoianu E, Moiceanu M, Plesca DA. Asthma Control Assessment in Children: Correlation between Asthma Control Test and Peak Expiratory Flow. Maedica (Bucur) 2014; 9:338.</a></li><li><a class="nounderline abstract_t">Gupta A, Gupta LK, Rehan HS, Prakash A. Response to inhaled corticosteroids on serum CD28, quality of life, and peak expiratory flow rate in bronchial asthma. Allergy Asthma Proc 2017; 38:13.</a></li><li><a class="nounderline abstract_t">Barnes PJ, Szefler SJ, Reddel HK, Chipps BE. Symptoms and perception of airway obstruction in asthmatic patients: Clinical implications for use of reliever medications. J Allergy Clin Immunol 2019; 144:1180.</a></li><li><a class="nounderline abstract_t">Choi IS, Koh YI, Lim H. Peak expiratory flow rate underestimates severity of airflow obstruction in acute asthma. Korean J Intern Med 2002; 17:174.</a></li><li><a class="nounderline abstract_t">Eid N, Yandell B, Howell L, et al. Can peak expiratory flow predict airflow obstruction in children with asthma? Pediatrics 2000; 105:354.</a></li><li><a class="nounderline abstract_t">Brand PL, Duiverman EJ, Waalkens HJ, et al. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group. Thorax 1999; 54:103.</a></li><li><a class="nounderline abstract_t">Giannini D, Paggiaro PL, Moscato G, et al. Comparison between peak expiratory flow and forced expiratory volume in one second (FEV1) during bronchoconstriction induced by different stimuli. J Asthma 1997; 34:105.</a></li><li><a class="nounderline abstract_t">Gautrin D, D'Aquino LC, Gagnon G, et al. Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic. Chest 1994; 106:1419.</a></li><li><a class="nounderline abstract_t">Jackson H, Hubbard R. Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey. BMJ 2003; 327:653.</a></li><li><a class="nounderline abstract_t">Martinez FJ, Mannino D, Leidy NK, et al. A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2017; 195:748.</a></li><li><a class="nounderline abstract_t">Reddel HK, Marks GB, Jenkins CR. When can personal best peak flow be determined for asthma action plans? Thorax 2004; 59:922.</a></li><li><a class="nounderline abstract_t">Dikshit MB, Raje S, Agrawal MJ. Lung functions with spirometry: an Indian perspective--I. Peak expiratory flow rates. Indian J Physiol Pharmacol 2005; 49:8.</a></li><li class="breakAll">Pedipress. Asthma peak flow diary. http://www.pedipress.com/dap_apfd_eng.html (Accessed on October 01, 2018).</li><li><a class="nounderline abstract_t">Charlton I, Charlton G, Broomfield J, Mullee MA. Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice. BMJ 1990; 301:1355.</a></li><li><a class="nounderline abstract_t">Thamrin C, Zindel J, Nydegger R, et al. Predicting future risk of asthma exacerbations using individual conditional probabilities. J Allergy Clin Immunol 2011; 127:1494.</a></li><li><a class="nounderline abstract_t">Gatheral TL, Rushton A, Evans DJ, et al. Personalised asthma action plans for adults with asthma. Cochrane Database Syst Rev 2017; 4:CD011859.</a></li><li><a class="nounderline abstract_t">Thamrin C, Taylor DR, Jones SL, et al. Variability of lung function predicts loss of asthma control following withdrawal of inhaled corticosteroid treatment. Thorax 2010; 65:403.</a></li><li><a class="nounderline abstract_t">Dinakar C, Oppenheimer J, Portnoy J, et al. Management of acute loss of asthma control in the yellow zone: a practice parameter. Ann Allergy Asthma Immunol 2014; 113:143.</a></li><li><a class="nounderline abstract_t">Gibson PG. Monitoring the patient with asthma: an evidence-based approach. J Allergy Clin Immunol 2000; 106:17.</a></li><li><a class="nounderline abstract_t">Perry TT, Marshall A, Berlinski A, et al. Smartphone-based vs paper-based asthma action plans for adolescents. Ann Allergy Asthma Immunol 2017; 118:298.</a></li><li><a class="nounderline abstract_t">Dobra R, Equi A. How to use peak expiratory flow rate. Arch Dis Child Educ Pract Ed 2018; 103:158.</a></li><li><a class="nounderline abstract_t">Côté J, Cartier A, Malo JL, et al. Compliance with peak expiratory flow monitoring in home management of asthma. Chest 1998; 113:968.</a></li><li><a class="nounderline abstract_t">Verschelden P, Cartier A, L'Archevêque J, et al. Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a three month period. Eur Respir J 1996; 9:880.</a></li><li><a class="nounderline abstract_t">Caress AL, Luker K, Beaver K, Woodcock A. Adherence to peak flow monitoring. Information provided by meters should be part of self management plan. BMJ 2002; 324:1157; author reply 1157.</a></li><li><a class="nounderline abstract_t">Wensley D, Silverman M. Peak flow monitoring for guided self-management in childhood asthma: a randomized controlled trial. Am J Respir Crit Care Med 2004; 170:606.</a></li><li><a class="nounderline abstract_t">Tierney WM, Roesner JF, Seshadri R, et al. Assessing symptoms and peak expiratory flow rate as predictors of asthma exacerbations. J Gen Intern Med 2004; 19:237.</a></li><li><a class="nounderline abstract_t">Garrett J, Fenwick JM, Taylor G, et al. Peak expiratory flow meters (PEFMs)--who uses them and how and does education affect the pattern of utilisation? Aust N Z J Med 1994; 24:521.</a></li><li><a class="nounderline abstract_t">Ignacio-Garcia JM, Gonzalez-Santos P. Asthma self-management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med 1995; 151:353.</a></li><li><a class="nounderline abstract_t">Cowie RL, Revitt SG, Underwood MF, Field SK. The effect of a peak flow-based action plan in the prevention of exacerbations of asthma. Chest 1997; 112:1534.</a></li><li><a class="nounderline abstract_t">Turner MO, Taylor D, Bennett R, Fitzgerald JM. A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med 1998; 157:540.</a></li><li><a class="nounderline abstract_t">Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ 1996; 312:748.</a></li><li><a class="nounderline abstract_t">Effectiveness of routine self monitoring of peak flow in patients with asthma. Grampian Asthma Study of Integrated Care (GRASSIC). BMJ 1994; 308:564.</a></li><li><a class="nounderline abstract_t">Jones KP, Mullee MA, Middleton M, et al. Peak flow based asthma self-management: a randomised controlled study in general practice. British Thoracic Society Research Committee. Thorax 1995; 50:851.</a></li><li><a class="nounderline abstract_t">Goldberg S, Springer C, Avital A, et al. Can peak expiratory flow measurements estimate small airway function in asthmatic children? Chest 2001; 120:482.</a></li><li><a class="nounderline abstract_t">Yoos HL, Kitzman H, McMullen A, et al. Symptom monitoring in childhood asthma: a randomized clinical trial comparing peak expiratory flow rate with symptom monitoring. Ann Allergy Asthma Immunol 2002; 88:283.</a></li><li><a class="nounderline abstract_t">Huang TT, Li YT, Wang CH. Individualized programme to promote self-care among older adults with asthma: randomized controlled trial. J Adv Nurs 2009; 65:348.</a></li><li><a class="nounderline abstract_t">Janson SL, McGrath KW, Covington JK, et al. Objective airway monitoring improves asthma control in the cold and flu season: a cluster randomized trial. Chest 2010; 138:1148.</a></li><li class="breakAll">American College of Emergency Physicians. Policy Resource and Education Paper for ACEP Policy Statement. Use of Peak Expiratory Flow Rate Monitoring for the Management of Asthma in Adults in the 
Emergency Department. https://www.acep.org/globalassets/uploads/uploaded-files/acep/clinical-and-practice-management/policy-statements/prep-papers/use-of-peak-expiratory-flow-et-al---prep-1007.pdf (Accessed on September 20, 2018).</li><li><a class="nounderline abstract_t">Jamison JP, McKinley RK. Validity of peak expiratory flow rate variability for the diagnosis of asthma. Clin Sci (Lond) 1993; 85:367.</a></li></ol></div><div id="topicVersionRevision">Topic 568 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="www.ginasthma.org/2023-gina-main-report" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : 2023 Global Initiative for Asthma (GINA) Report: Global Strategy for Asthma Management and Prevention. www.ginasthma.org/2023-gina-main-report (Accessed on May 15, 2023).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : National Asthma Education and Prevention Program: Expert Panel Report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD. National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051) www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on September 19, 2018).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8950932" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : [Comparison of different types of peak flow meter and reference values for peak expiratory flow (PEF) for healthy Japanese subjects].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8950932" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : [Comparison of different types of peak flow meter and reference values for peak expiratory flow (PEF) for healthy Japanese subjects].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8950932" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : [Comparison of different types of peak flow meter and reference values for peak expiratory flow (PEF) for healthy Japanese subjects].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10489825" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The effect of patient technique and training on the accuracy of self-recorded peak expiratory flow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9872837" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Spirometric reference values from a sample of the general U.S. population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19863291" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Peak expiratory flow in normals: comparison of the mini Wright versus spirometric predicted peak flows.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7193594" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Diurnal variation in peak expiratory flow in asthmatics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18417507" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Reference values for peak flow and FEV1 variation in healthy schoolchildren using home spirometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10390464" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Diurnal variability--time to change asthma guidelines?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17092844" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Home monitoring in asthma self-management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25705302" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Asthma Control Assessment in Children: Correlation between Asthma Control Test and Peak Expiratory Flow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28234041" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Response to inhaled corticosteroids on serum CD28, quality of life, and peak expiratory flow rate in bronchial asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31330221" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Symptoms and perception of airway obstruction in asthmatic patients: Clinical implications for use of reliever medications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12298428" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Peak expiratory flow rate underestimates severity of airflow obstruction in acute asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10654955" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Can peak expiratory flow predict airflow obstruction in children with asthma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10325912" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9088296" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Comparison between peak expiratory flow and forced expiratory volume in one second (FEV1) during bronchoconstriction induced by different stimuli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7956394" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14500437" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27783539" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15516464" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : When can personal best peak flow be determined for asthma action plans?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15881854" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Lung functions with spirometry: an Indian perspective--I. Peak expiratory flow rates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15881854" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Lung functions with spirometry: an Indian perspective--I. Peak expiratory flow rates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2148702" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21333347" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Predicting future risk of asthma exacerbations using individual conditional probabilities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28394084" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Personalised asthma action plans for adults with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20435861" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Variability of lung function predicts loss of asthma control following withdrawal of inhaled corticosteroid treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25065350" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Management of acute loss of asthma control in the yellow zone: a practice parameter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10887300" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Monitoring the patient with asthma: an evidence-based approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28111110" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Smartphone-based vs paper-based asthma action plans for adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29150424" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : How to use peak expiratory flow rate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9554633" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Compliance with peak expiratory flow monitoring in home management of asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8793446" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a three month period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12003900" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Adherence to peak flow monitoring. Information provided by meters should be part of self management plan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15184205" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Peak flow monitoring for guided self-management in childhood asthma: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15009778" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Assessing symptoms and peak expiratory flow rate as predictors of asthma exacerbations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7848156" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Peak expiratory flow meters (PEFMs)--who uses them and how and does education affect the pattern of utilisation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7842191" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Asthma self-management education program by home monitoring of peak expiratory flow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9404750" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The effect of a peak flow-based action plan in the prevention of exacerbations of asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9476870" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8605463" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Randomised comparison of guided self management and traditional treatment of asthma over one year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8148679" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Effectiveness of routine self monitoring of peak flow in patients with asthma. Grampian Asthma Study of Integrated Care (GRASSIC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7570436" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Peak flow based asthma self-management: a randomised controlled study in general practice. British Thoracic Society Research Committee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11502647" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Can peak expiratory flow measurements estimate small airway function in asthmatic children?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11926622" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Symptom monitoring in childhood asthma: a randomized clinical trial comparing peak expiratory flow rate with symptom monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19040689" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Individualized programme to promote self-care among older adults with asthma: randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20538819" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Objective airway monitoring improves asthma control in the cold and flu season: a cluster randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20538819" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Objective airway monitoring improves asthma control in the cold and flu season: a cluster randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8403810" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Validity of peak expiratory flow rate variability for the diagnosis of asthma.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
